Conclusions: These results demonstrate the existence of a novel population of resident SMC progenitor cells expressing PW1 and participating in PH-associated vascular remodeling.
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PAH Pulmonary Arterial Hypertension PH Pulmonary Hypertension CH chronic hypoxia MCT monocrotaline SMC smooth muscle cell α-SMA alpha-smooth muscle actin CNN1 calponin SM-MHC smooth muscle myosin heavy chain EC endothelial cell RVSP right ventricular systolic pressure SDF-1
Stromal-derived factor-1 MIF Macrophage migration inhibitory factor BM bone marrow.
INTRODUCTION
Pulmonary arterial hypertension (PAH), a rare and severe disease with no curative options, is characterized by a sustained increase in pulmonary vascular resistance leading to right heart failure and death 1 . Histologically, PAH is associated with neomuscularization of small pulmonary vessels, medial hypertrophy, neointima formation, endothelial proliferation, excessive extracellular matrix deposition and recruitment of inflammatory cells in the vascular wall [2] [3] [4] . To date, the cellular origin of neomuscularization and medial hypertrophy remain unknown. It was proposed that new smooth muscle cells (SMC) are derived from resident SMC that re-enter a proliferative state 5 or from pericytes 6, 7 and/or from endothelial cells (EC) that adopt a smooth muscle fate 8 . Recent studies suggest that SMC originate from the proliferation and differentiation of either resident as well as circulating bone marrow (BM)-derived progenitor cells 9 . Indeed, various types of resident SMC progenitor cells have been identified in numerous adult organs, including the lung. They are located in the vessel or in the perivascular zone and express several stem cells markers including Sca-1, c-kit, PDFGR-α or CD34 or mesenchymal stem cells markers 10, 11 . In addition, perivascular cells identified by these same markers and expressing CD146, NG2 and PDGFR-β were also recognized as SMC progenitor cells 12 .
Recently, a population of interstitial progenitor cells was identified in mouse skeletal muscle based on their expression of the PW1 protein 13 which are capable of giving rise to smooth and skeletal muscle as well as adipocytes in culture 14, 15 . These PW1-expressing cells were found in multiple adult tissues including skin, gut, BM and the central nervous system 14 . Pw1 gene encodes a zinc-finger protein that has been shown to regulate cell cycle and cell stress responses due to inflammation 16 and p53 17 . In addition, PW1 mediates β-catenin stability in the Wnt signalling pathway 18 . PW1 has also been shown to function as a transcription factor with a DNA-binding motif regulating a large array of genes involved in metabolic homeostasis 19 . Moreover, PW1 expression is required for the myogenic and migratory capacities of both mouse and human mesoangioblasts, reinforcing the relevance of PW1 to identify competent mesoangioblasts prior to their use in stem cell-mediated therapeutic applications 20 .
Given the distribution of PW1 expression in a wide array of adult somatic stem cells and the role of PW1 in cell stress responses, we investigated whether PW1 + progenitor cells present in lung tissue are recruited to proliferate and differentiate into SMCs during vascular remodeling during chronic hypoxia (CH)-induced PH. To address this hypothesis, we used a PW1-reporter transgenic mouse, PW1 nLacZ/+ , that expresses the nuclear β-galactosidase within the Pw1 gene context 14 . These mice carry the β-galactosidase coding sequence (β-gal) driven under the control of Pw1 and due to the high level and stability of the reporter gene product 21 , we can identify cells recently derived from reporter expressing progenitor cells. In this study, we used this reporter mouse to examine the role of the PW1 + progenitor cells in vascular remodeling during CH. We identified two resident PW1 + progenitor cell populations located in the lung parenchyma and in perivascular zones of small pulmonary vessels, which show an early recruitment and a potential to differentiate into SMCs during CH. Our results strongly suggest that new SMC derive from resident PW1 
METHODS
Detailed methods are provided in the online data supplement.
Pw1IRESnLacZ transgenic mice (Pw1

nlacZ/+
) bear a nuclear operon lactose gene expressed under the control of the Pw1 gene locus 18 . Mice (littermates of 6-8 weeks) were exposed to room air (normoxia) or chronic normobaric hypoxia (10% O 2 ) for 4 or 28 days. Fluorescence-activated cell sorting (FACS) was used to isolate the pulmonary PW1 + cell populations based on their β-gal activity and a combination of progenitor markers. Lethally irradiated C57BL6/J mice were reconstituted with BM cells of age and sex-matched GFP + /β-gal + (H2B-GFPxPw1 nLacz/+ ) mice and exposed, after 9 months, to Normoxia (N) or CH for 4 days (CH 4d).
RESULTS
Mouse pulmonary PW1
+ cells are present in perivascular and parenchymal zones, express progenitor and pericyte markers and differentiate into SMC.
PW1 expression was found to identify adult stem and progenitor cells in multiple organs 14, 15, 20 although previous studies did not report on expression in the lung. PW1 protein expression was detected by immunofluorescence in cells located in parenchymal and perivascular spaces, near small non-muscularized and muscularized vessels ( Figure 1A and 1B). We characterized these progenitor cells from PW1-reporter mice after FACS purification based on β-galactosidase activity + cells were positive for pericyte markers NG2 (84 ± 7.3%, n=2) and PDGFR-β (86 ± 5.3%, n=2) and negative for CD31 (data not shown) (Online Figure II) . Immunofluorescence studies confirmed that, in the lung, PW1 expression partially colocalized with progenitor markers CD146, c-kit and PDGFR-α ( Figure 1E ).
To investigate in vitro the potentials of these progenitor cells for differentiation in SMC, freshly sorted PW1 + cell populations were studied for SMC markers either upon isolation or after cell culture and differentiation induction. Figure 4A ) was found to be significantly increased in MCT-treated rats as compared with control animals (11.7 ± 3.1% vs 20 ± 2%, p≤0.05) indicating that PW1 + cells are mobilized during PH independently of the experimental model used ( Figure 4B ).
CH-induced neomuscularization is associated with an increased number of PW1
+ cells-derived SMC.
We next studied the number of SMC differentiated from PW1 + cells during CH-induced vascular remodeling in PW1-reporter mice during CH for 4 or 28 days. After 4 days of CH, we observed neomuscularization without any increase in vascular wall thickness whereas after 28 days, both features were observed ( Figure 5A and 5B). RVSP was already increased after 4 days of CH while the cardiac right hypertrophy, estimated by the Fulton index, was not modified at 4 days but significantly increased after 28 days of CH (Online Figures VII-A , VII-B, VII-C).
The number of β-gal + SMC in small pulmonary vessels (<100 µm), as determined by coimmunofluorescence, was significantly increased after 4 days of CH as compared with normoxia indicating an increased percentage of SMC recently derived from PW1 + cells at an early stage during the neomuscularization phase of CH-induced vascular remodeling ( Figure 5C ). This early increase was confirmed by using a more-specific SMC marker, calponin (CNN1) (Online Figure III) . These observations suggest that newly formed SMC during vessel neomuscularization are derived from PW1 + progenitor cells. This is supported by the observation that the number of PW1 + cells ( Figure 3B ) and of PW1 + -derived β-gal + SMC ( Figure 5C ) both return to basal levels at 28 days of CH indicating that PW1 + cells and β-gal + SMC follow similar kinetics. These observations do not exclude the possibility that SMC or myofibroblasts dedifferentiate into PW1-expressing cells during CH to proliferate and further differentiate into SMC. We therefore analyzed mouse lungs for co-expression of PW1 and α-SMA at 0, 1, 2, 3 and 4 days of CH. We found few cells co-expressing both α-SMA and PW1 at all time points (from 2.5 to 7% of all α-SMA 
Pulmonary PW1 + cells differentiation into vascular SMCs during CH is dependent on the CXCR4 pathway.
The SDF-1/CXCR4 pathway is an important regulator of stem and progenitor cells mobilization and homing. We hypothesized that the SDF-1/CXCR4 pathway plays an important role in the recruitment of the pulmonary PW1 + cells during CH. We therefore studied the effect of AMD3100, a CXCR4 antagonist, on PW1 + cells proliferation and differentiation and on vascular remodeling after 4 days of CH. AMD3100 treatment did not modify hematocrit values (data not shown). Based on flow cytometry analysis, we showed that the PW1 + progenitor cells are mainly positive for CXCR4 ( Figure 6A ). FACS analyses also showed that the number of cells of each PW1 + population was not modified by AMD3100 treatment neither in normoxia nor after CH ( Figure 6B ). We observed however by co-immunofluorescence that AMD3100 treatment completely prevented the increase in PW1 + -derived β-gal + vascular SMC obtained after CH but had no effect in normoxia ( Figure 6C ). These results indicate that the CXCR4 pathway regulates the migration and/or differentiation of PW1 + progenitor cells into vascular SMC but does not regulate PW1 + progenitor cells' proliferation. In addition, AMD3100 treatment partially but significantly inhibited pulmonary vessels neomuscularization during CH without effect during normoxia ( Figure 6D ). These results indicate that CXCR4 pathway participates in the control of CH-induced neomuscularization.
Resident pulmonary PW1 + cells are recruited during early CH.
Previously, we have shown that the BM contains PW1 + cells that correspond to the BM progenitor populations 14 . It has been suggested that the SMC cells that form in the lung in response to CH derive from circulating cells of BM origin 9 . Therefore, we performed a total BM transplantation from PW1-reporter mice crossed with H2B-GFP mice (expressing ubiquitous nuclear GFP fused to histone2B) onto lethally irradiated WT mice. After 8 months, chimerism was evaluated at ~82% (82.2 ± 4.2%, n=10) in the grafted mice blood by FACS analysis of GFP 
PW1
+ progenitor cells are present in the human lung and accumulate in remodeled vessels.
Our results reveal that a resident population of PW1 + cells is present in the lung that respond to CH and generate SMCs. While the mouse can often serve to unravel cellular events in human disease progression, we set out to determine whether PW1 + cells are present in the human lung and to study them in the pathological context of PAH. We performed immunofluorescence on biopsies obtained from the healthy region of lung samples from cancer patients (control) and on PAH human lung samples. Patients' characteristics are indicated in Online Table I . Similar to our observations from mouse lungs, we found PW1 . These markers have also been used to isolate vascular progenitor cells in other adult organs in rodents and human. In various tissues, resident progenitor cells expressing CD34 10, 23, 24 , c-kit 24, 25 or PDGFR-α 25 differentiate into SMC. Resident pulmonary c-kit + cells in particular have been recently described in human as multipotent stem cells able to generate pulmonary vessels 26 . We also report here the presence of a CD34 -/PW1 + population expressing pericyte markers similar to the perivascular progenitor cells identified in multiple human organs 12 . Interestingly, PW1 expression has been recently demonstrated to be essential for progenitor competence in mesoangioblasts that are derived from vessels present in skeletal muscle 20 . Thus, the pulmonary PW1 + cell populations identified here are consistent with previously published vascular progenitor cells and confirm that PW1 identifies multiple progenitor cell populations. Using PW1-reporter mice 14 , we were able to follow the differentiation of these PW1 which contribute to pulmonary vessels remodeling [28] [29] [30] . Yet, few studies have been able to address the question of the mobilization of resident pulmonary progenitor cells. Long term CH induces the proliferation of resident endothelial progenitor cells in the mouse lung 31 . Lineage-tracing experiments have shown that a perivascular lung mesenchymal stem cell population contributes to microvascular remodeling after 5 weeks of hypobaric hypoxia 32 . Ricard et al. 7 showed that NG2 + pericytes which contribute to forming SMC-like cells, are increased from day 7 to day 21 of CH demonstrating a later and more progressive recruitment of these cells in this model. This is consistent with our results, which indicate that the number of PW1 34 or the atherosclerosis 35 . These resident progenitor cells contribute to maintain the tissue homeostasis and integrity and were proposed to be responsible for pathological features such as the SMCs-like accumulation in remodeled vessels 9 .
The SDF-1/CXCR4 pathway is one of the major regulators of progenitor and stem cells recruitment and homing 36 . In addition, pulmonary concentrations of CXCR4 ligands stromal-derived factor 1 (SDF-1) and macrophage migration inhibitory factor (MIF) were found to be elevated during CH 37, 38 and CXCR4 inhibition by AMD3100 treatment was shown to partially prevent CH-induced increase in media thickness 30 . Consistent with these results, we here show that the increase in the number of PW1 + -derived SMC and the neomuscularization are blocked by AMD3100, indicating that they are dependent on the CXCR4 pathway. Although we cannot prove yet whether PW1 + progenitor cells are directly activated through the CXCR4 receptor, our observation that most PW1 + progenitor cells express CXCR4 suggests that the CXCR4 ligand may directly attract them to the vessels. Interestingly, our result shows that the CXCR4 pathway regulates PW1 + progenitor cells migration and/or differentiation but not their proliferation. This result is consistent with the major homing effect of the SDF-1/CXCR4 pathway but this indicates that further studies are needed to understand which factors are responsible for inducing proliferation of PW1 + progenitor cells during early CH. It would be particularly interesting to study the effect of PAH-specific drugs on the proliferation, migration and differentiation of PW1 + cells or to target pathways which regulate pulmonary vascular remodeling such as serotonin, PDGF or HIF-1α pathways 39 . We report here a similar increase in the number of lung parenchymal PW1 + cells in two well-recognized and widely used experimental models, the MCT-and the CH-induced PH models. Both models induce inflammation as an initial process 40, 41 and inflammatory cytokines, such as MCP-1, TNF-α or IL-10, play a crucial role in the proliferation and differentiation capacities of stem/progenitor cells 42 . Another common mechanism between the two models could involve HIF-1α as it is well established that inflammation causes a hypoxia-independent HIF-1α activation in response to the pro-inflammatory IL-1β 43 . HIF-1α regulates stem cells mobilization 44 and could therefore be involved in the recruitment of PW1 . These PW1 + progenitor cells were mainly absent from non-remodeled vessel walls but we found numerous PW1 + cells within the vascular wall and perivascular zone of the remodeled vessels in PAH patients. This result confirms previous observations that progenitor cells are present in remodeled pulmonary arteries in lung tissues from PAH patients 45, 46 . Interestingly, numerous PW1 + /α-SMA + cells were present in the hypertrophic media and in the neointima. We did not observe these features in the mouse lung vessels after 28 days of CH (data not shown). As human PAH lung samples are obtained from transplanted patients with an end-stage disease, the severe inflammatory context and the proliferative and SMC-like/myofibroblast dedifferentiation conditions could be involved in maintaining the PW1 expression in these mature and dysfunctional cells. This is supported by the sustained increase in the number of pulmonary PW1 + cells observed in the MCT treated-rat model after 21 days whereas in the chronic hypoxic mouse model this number is back to control levels after 28 days of CH. This suggests that the sustained mobilization of pulmonary PW1 + cells is associated with the severity of the PH disease. DOI : 10.1161/CIRCRESAHA.115.307035 9
In conclusion, we show here that the lung contains three myogenic PW1 + progenitor cell populations that are resident in parenchymal and perivascular zones in the adult mouse lung. Based on their myogenic capacities both in vivo and in vitro, and on our immunofluorescence and FACS observations on normoxic and CH-submitted mouse lungs, we suggest that the three pulmonary PW1 

In human, PW1-expressing cells were also present near pulmonary arterioles and were found abundant in remodeled vascular structures of PAH patients.
Neomuscularization of pulmonary arterioles and vascular SMCs proliferation are characteristic pathological features of PAH and contribute to reducing vascular compliance. The origin of the new vascular SMCs is not clearly established. In this study, we present evidence that these new vascular SMCs, which appear around previously not or partially muscularized small pulmonary vessels during PAH, are derived from PW1-expressing resident vascular progenitor cells. We have used an original transgenic mouse tool which allows detection of PW1-expressing progenitor cells and of cells recently derived from these progenitors. We have shown that mouse pulmonary PW1 + progenitor cells are perivascular and that they can differentiate into vascular SMCs in vitro and in vivo. Chronic hypoxia in mice induced the mobilization of these resident progenitor cells and their differentiation into new vascular SMCs in a CXCR4 dependent manner. PW1-expressing cells were also present in the human lung and were found abundant in remodeled vascular structures of PAH patients suggesting that these progenitor cells also contribute to pulmonary vascular remodeling in human. These results identify pulmonary PW1-expressing cells as a new resident progenitor cell population that participates in small vessel muscularization during PAH development and provide a new potential therapeutic target. 
BrdU (5'-bromo-2'-deoxyuridine) injections
Normoxic and chronic hypoxic mice were injected i.p. with BrdU solution (Sigma, sc-290815A) prepared in PBS (100 mg/kg) at 24, 16 and 4 hours before euthanasia.
AMD3100 injections
Normoxic and chronic hypoxic mice were injected daily i.p. with AMD3100 solution (ref. A5602, Sigma-Aldrich) prepared in PBS (10mg/kg) from day 1 to day 4.
Haemodynamic measurements and tissue collection
Mice were anesthetized with a ketamine/Xylazine mix (100 and 10 mg/kg i.p.) and maintained at Alternatively, lungs were inflated and fixed by injecting Finefix (Milestone Srl) directly in lobes.
After fixation for 24h à 4°C, lung tissues were paraffin-embedded.
FACS analysis
Lung single-cell suspensions were obtained by digestion the tissues in DMEM high glucose media 
Immunofluorescent labeling
Tissue 10μm thick cryosections were fixed in formalin (Sigma). Tissue paraffin-embedded 4μm thick sections were deparaffinised, rehydrated, and citrate antigen retrieval was performed. Sorted cells were centrifuged in 150 μL PBS onto a gelatin-coated slide using a Cytospin 3 cytocentrifuge (Shandon Instruments, PA) and were fixed in formalin (Sigma). Then cryosections and cytospun cells were permeabilized in methanol (6 min at -20°C) or with X-100 triton 0.01% in PBS (5 min at RT).
Non specific binding was blocked with bovine serum albumin 10% in PBS (1h at RT) and sections were incubated overnight with PBS + primary Abs (see Online Table III ) at 4°C. Secondary Abs and DAPI (DAPI) were diluted in PBS (respectively 1/500 and 1/1000) and incubated 45 min at RT.
Immunolabeled sections were mounted with Dako fluorescent mounting medium (Dako) and examined under confocal microscope (Leica SPE confocal microscope). In some cases, as indicated, images were acquired with a cooled CoolSnap camera (Roper-Scientific) on an Olympus epifluorescent microscope (60x, UPlanSApo, 0.17). Images were processed and analyzed using Metamorph software (Molecular Devices) supplemented with the 3D-deconvolution module. For each sample, a series of consecutive planes (stack of images) were acquired (sectioning step, 0.2 μm) and deconvoluted using acquired point spread function. Control experiments were performed using secondary antibodies alone and showed no non-specific labeling.
Quantitative analysis by immunofluorescent microscopy
Images were analyzed by an investigator blinded to the experimental status of all animals. β-gal + and β-gal -/α-SMA + SMC were counted for all fully muscularized vessels (<100 µm) of one lung section per animal (15-30 vessels/animal) using stacks of 5-10 consecutive planes for one image to ensure colocalization of the nuclear labeling of β-gal and the cytoplasmic labeling of α-SMA. For other countings, single planes were analyzed for each image and a minimum of 30 to 60 fields were analyzed per animal.
Muscularization was measured by immunofluorescence in using using anti-α-SMA and anti-vWF antibodies. Vessels showing a perimeter with more than 90% of muscularization were considered fully muscularized. Medial thickness was measured as wall-to-lumen ratio. days.
Statistical analysis
All values were expressed as the mean ± SEM. Statistics were performed using the computer program GraphPad PRISM 6 (GraphPad software) or XLStat 2013 (Addinsoft, New York, USA) with a nonparametric Mann and Whitney test for single comparisons. Multiple comparisons were analyzed using Kruskall-Wallis test followed by Dunn post-hoc test. P values less than 0.05 were considered to be significant.
Study approval
Experiments for the project were approved by our institutional review board (authorizations 
